Bausch Health Companies Inc (BHC) - Net Assets
Based on the latest financial reports, Bausch Health Companies Inc (BHC) has net assets worth CA$-1.08 Billion CAD (≈ $-782.70 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$24.50 Billion ≈ $17.72 Billion USD) and total liabilities (CA$25.58 Billion ≈ $18.50 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Bausch Health Companies Inc (BHC) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$-1.08 Billion |
| % of Total Assets | -4.42% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -88.45% |
| Growth Volatility | 169.34 |
Bausch Health Companies Inc - Net Assets Trend (1993–2025)
This chart illustrates how Bausch Health Companies Inc's net assets have evolved over time, based on quarterly financial data. See BHC cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Bausch Health Companies Inc (1993–2025)
The table below shows the annual net assets of Bausch Health Companies Inc from 1993 to 2025. For live valuation and market cap data, see Bausch Health Companies Inc (BHC) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CA$376.31 Million ≈ $272.22 Million |
+216.87% |
| 2024-12-31 | CA$-322.00 Million ≈ $-232.93 Million |
-292.68% |
| 2023-12-31 | CA$-82.00 Million ≈ $-59.32 Million |
-131.54% |
| 2022-12-31 | CA$260.00 Million ≈ $188.08 Million |
+864.71% |
| 2021-12-31 | CA$-34.00 Million ≈ $-24.60 Million |
-105.62% |
| 2020-12-31 | CA$605.00 Million ≈ $437.65 Million |
-46.74% |
| 2019-12-31 | CA$1.14 Billion ≈ $821.77 Million |
-59.64% |
| 2018-12-31 | CA$2.81 Billion ≈ $2.04 Billion |
-52.64% |
| 2017-12-31 | CA$5.94 Billion ≈ $4.30 Billion |
+82.44% |
| 2016-12-31 | CA$3.26 Billion ≈ $2.36 Billion |
-45.97% |
| 2015-12-31 | CA$6.03 Billion ≈ $4.36 Billion |
+10.95% |
| 2014-12-31 | CA$5.43 Billion ≈ $3.93 Billion |
+3.84% |
| 2013-12-31 | CA$5.23 Billion ≈ $3.79 Billion |
+40.78% |
| 2012-12-31 | CA$3.72 Billion ≈ $2.69 Billion |
-7.23% |
| 2011-12-31 | CA$4.01 Billion ≈ $2.90 Billion |
-18.41% |
| 2010-12-31 | CA$4.91 Billion ≈ $3.55 Billion |
+262.61% |
| 2009-12-31 | CA$1.35 Billion ≈ $979.73 Million |
+12.71% |
| 2008-12-31 | CA$1.20 Billion ≈ $869.22 Million |
-7.41% |
| 2007-12-31 | CA$1.30 Billion ≈ $938.82 Million |
+1.01% |
| 2006-12-31 | CA$1.28 Billion ≈ $929.45 Million |
-6.86% |
| 2005-12-31 | CA$1.38 Billion ≈ $997.94 Million |
+1.56% |
| 2004-12-31 | CA$1.36 Billion ≈ $982.59 Million |
+54.08% |
| 2003-12-31 | CA$881.60 Million ≈ $637.73 Million |
+4.25% |
| 2002-12-31 | CA$845.69 Million ≈ $611.76 Million |
-24.90% |
| 2001-12-31 | CA$1.13 Billion ≈ $814.58 Million |
+374.22% |
| 2000-12-31 | CA$237.46 Million ≈ $171.77 Million |
-45.45% |
| 1999-12-31 | CA$435.30 Million ≈ $314.89 Million |
+750.20% |
| 1998-12-31 | CA$51.20 Million ≈ $37.04 Million |
-32.19% |
| 1997-12-31 | CA$75.50 Million ≈ $54.62 Million |
+104.61% |
| 1996-12-31 | CA$36.90 Million ≈ $26.69 Million |
+152.74% |
| 1995-12-31 | CA$14.60 Million ≈ $10.56 Million |
+89.61% |
| 1994-12-31 | CA$7.70 Million ≈ $5.57 Million |
+396.15% |
| 1993-12-31 | CA$-2.60 Million ≈ $-1.88 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Bausch Health Companies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 963260751000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CA$10.50 Billion | % |
| Other Comprehensive Income | CA$-1.76 Billion | % |
| Other Components | CA$356.35 Million | % |
| Total Equity | CA$-552.99 Million | 100.00% |
Bausch Health Companies Inc Competitors by Market Cap
The table below lists competitors of Bausch Health Companies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Droneshield Ltd
AU:DRO
|
$1.87 Billion |
|
CETC Digital Technology Co Ltd
SHG:600850
|
$1.87 Billion |
|
Beijing Dabeinong Technology Group Co Ltd
SHE:002385
|
$1.88 Billion |
|
Farglory Land Development Co Ltd
TW:5522
|
$1.88 Billion |
|
China Yuchai International Limited
NYSE:CYD
|
$1.87 Billion |
|
G2 Goldfields Inc.
TO:GTWO
|
$1.87 Billion |
|
Shenzhen Forms Syntron Information Co Ltd
SHE:300468
|
$1.87 Billion |
|
S-1 Corp
KO:012750
|
$1.87 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bausch Health Companies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -1,279,000,000 to -552,991,803, a change of 726,008,197.
- Net income of 159,748,368 contributed positively to equity growth.
- Other comprehensive income increased equity by 422,202,936.
- Other factors increased equity by 144,056,893.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$159.75 Million | +28.89% |
| Other Comprehensive Income | CA$422.20 Million | +76.35% |
| Other Changes | CA$144.06 Million | +26.05% |
| Total Change | CA$- | % |
Book Value vs Market Value Analysis
This analysis compares Bausch Health Companies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1993-12-31 | CA$-0.10 | CA$6.93 | x |
| 1994-12-31 | CA$0.09 | CA$6.93 | x |
| 1995-12-31 | CA$0.15 | CA$6.93 | x |
| 1996-12-31 | CA$0.37 | CA$6.93 | x |
| 1997-12-31 | CA$0.75 | CA$6.93 | x |
| 1998-12-31 | CA$0.48 | CA$6.93 | x |
| 1999-12-31 | CA$4.02 | CA$6.93 | x |
| 2000-12-31 | CA$1.65 | CA$6.93 | x |
| 2001-12-31 | CA$7.47 | CA$6.93 | x |
| 2002-12-31 | CA$5.27 | CA$6.93 | x |
| 2003-12-31 | CA$5.51 | CA$6.93 | x |
| 2004-12-31 | CA$8.44 | CA$6.93 | x |
| 2005-12-31 | CA$8.64 | CA$6.93 | x |
| 2006-12-31 | CA$8.03 | CA$6.93 | x |
| 2007-12-31 | CA$8.07 | CA$6.93 | x |
| 2008-12-31 | CA$7.52 | CA$6.93 | x |
| 2009-12-31 | CA$8.54 | CA$6.93 | x |
| 2010-12-31 | CA$25.08 | CA$6.93 | x |
| 2011-12-31 | CA$12.29 | CA$6.93 | x |
| 2012-12-31 | CA$12.17 | CA$6.93 | x |
| 2013-12-31 | CA$15.95 | CA$6.93 | x |
| 2014-12-31 | CA$15.56 | CA$6.93 | x |
| 2015-12-31 | CA$17.02 | CA$6.93 | x |
| 2016-12-31 | CA$9.08 | CA$6.93 | x |
| 2017-12-31 | CA$16.63 | CA$6.93 | x |
| 2018-12-31 | CA$7.81 | CA$6.93 | x |
| 2019-12-31 | CA$3.02 | CA$6.93 | x |
| 2020-12-31 | CA$1.51 | CA$6.93 | x |
| 2021-12-31 | CA$-0.30 | CA$6.93 | x |
| 2022-12-31 | CA$-1.91 | CA$6.93 | x |
| 2023-12-31 | CA$-2.80 | CA$6.93 | x |
| 2024-12-31 | CA$-3.48 | CA$6.93 | x |
| 2025-12-31 | CA$-1.47 | CA$6.93 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bausch Health Companies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.53%
- • Asset Turnover: 0.40x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-2.07%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1993 | 0.00% | 35.14% | 0.48x | 0.00x | CA$4.38 Million |
| 1994 | 123.38% | 54.91% | 0.68x | 3.32x | CA$8.73 Million |
| 1995 | 40.41% | 28.64% | 0.34x | 4.17x | CA$4.44 Million |
| 1996 | 61.52% | 34.19% | 1.13x | 1.59x | CA$19.01 Million |
| 1997 | 46.62% | 42.72% | 0.88x | 1.24x | CA$27.65 Million |
| 1998 | 88.67% | 40.25% | 0.56x | 3.90x | CA$40.28 Million |
| 1999 | 14.36% | 35.41% | 0.28x | 1.46x | CA$18.97 Million |
| 2000 | -62.32% | -47.86% | 0.28x | 4.66x | CA$-171.72 Million |
| 2001 | 7.77% | 14.99% | 0.44x | 1.18x | CA$-25.16 Million |
| 2002 | 10.38% | 11.14% | 0.43x | 2.17x | CA$3.23 Million |
| 2003 | -3.09% | -3.31% | 0.43x | 2.18x | CA$-115.42 Million |
| 2004 | 3.88% | 5.95% | 0.44x | 1.48x | CA$-83.08 Million |
| 2005 | 6.45% | 9.52% | 0.43x | 1.59x | CA$-48.93 Million |
| 2006 | 15.87% | 19.05% | 0.49x | 1.69x | CA$75.45 Million |
| 2007 | 15.07% | 23.20% | 0.47x | 1.37x | CA$65.76 Million |
| 2008 | 16.64% | 26.40% | 0.47x | 1.35x | CA$79.74 Million |
| 2009 | 13.03% | 21.51% | 0.40x | 1.53x | CA$41.02 Million |
| 2010 | -4.24% | -17.62% | 0.11x | 2.20x | CA$-699.30 Million |
| 2011 | 3.98% | 6.48% | 0.19x | 3.28x | CA$-241.14 Million |
| 2012 | -3.12% | -3.27% | 0.20x | 4.83x | CA$-487.76 Million |
| 2013 | -16.92% | -15.01% | 0.21x | 5.46x | CA$-1.38 Billion |
| 2014 | 17.20% | 11.05% | 0.31x | 4.96x | CA$382.28 Million |
| 2015 | -4.50% | -2.54% | 0.21x | 8.28x | CA$-857.30 Million |
| 2016 | -76.43% | -24.90% | 0.22x | 13.81x | CA$-2.72 Billion |
| 2017 | 41.10% | 27.56% | 0.23x | 6.41x | CA$1.82 Billion |
| 2018 | -151.77% | -49.50% | 0.31x | 10.04x | CA$-4.42 Billion |
| 2019 | -167.73% | -20.73% | 0.25x | 31.86x | CA$-1.89 Billion |
| 2020 | -104.49% | -6.96% | 0.26x | 58.32x | CA$-612.50 Million |
| 2021 | 0.00% | -11.11% | 0.29x | 0.00x | CA$-926.40 Million |
| 2022 | 0.00% | -2.61% | 0.32x | 0.00x | CA$-142.80 Million |
| 2023 | 0.00% | -6.76% | 0.32x | 0.00x | CA$-489.80 Million |
| 2024 | 0.00% | -0.48% | 0.36x | 0.00x | CA$81.90 Million |
| 2025 | 0.00% | 1.53% | 0.40x | 0.00x | CA$215.05 Million |
Industry Comparison
This section compares Bausch Health Companies Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $132,318,484
- Average return on equity (ROE) among peers: -67.72%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | CA$-1.08 Billion | 0.00% | N/A | $1.87 Billion |
| Aurora Cannabis Inc (ACB) | $1.69 Million | -10.52% | 0.00x | $171.89 Million |
| Amotiv Limited (AOV) | $795.11 Million | 0.54% | 0.21x | $576.83 Million |
| Aequus Pharmaceuticals Inc (AQS) | $-6.45 Million | 0.00% | 0.00x | $479.73K |
| Avicanna Inc (AVCN) | $3.46 Million | -426.03% | 4.09x | $12.28 Million |
| Avant Brands Inc (AVNT) | $32.85 Million | -68.65% | 0.81x | $6.98 Million |
| CanadaBis Capital Inc (CANB) | $2.63 Million | 23.10% | 4.88x | $1.53 Million |
| Cannabist Company Holdings Inc (CBST) | $266.93 Million | -39.33% | 0.51x | $12.41 Million |
| Cipher Pharmaceuticals Inc (CPH) | $18.41 Million | -56.20% | 0.05x | $297.74 Million |
| Cardiol Therapeutics Inc Class A (CRDL) | $76.24 Million | -32.43% | 0.15x | $118.76 Million |
About Bausch Health Companies Inc
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmac… Read more